Ph3Location /h3pHybrid: Basel, Switzerland /ph3Overview /h3pLead the Diseases Area (DA) Access team, strategically and operationally, across the R‑D‑C continuum, working in partnership with strategic Commercial Launch Strategy DAs, Medical Affairs, and Novartis Regions and priority Country teams to maximize access to Novartis assets. /ph3Key Responsibilities /h3ulliSupporting the Global (VA) TA Head; representing Access talent and topics with internal partners and external stakeholders. Internally, drive vision, inspire and provide leadership throughout the Access community (International, Regions, Countries) and with key partners (CPS/International, Development, Biomedical Research, Operations, SG, Regions and Countries). Externally, represent Novartis in appropriate fora and organizations to drive the Novartis strategic access agenda. /liliDeveloping and operationalizing the Integrated Product Access strategy. Collaborate and partner with TAs, Medical Affairs, Development and Biomedical Research to enhance the value proposition, access strategy and access‑relevant evidence packages. Ensure access landscaping and payer evidence requirements are built into TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization. /liliCreate and champion a compelling and competitive global strategic vision for how Novartis will innovate and expand access through DAs for the benefit of patients, Healthcare Systems, Payers, and Novartis. Provide active leadership in internal fora, enable broad country insights and alignment, and leverage external fora to pressure‑test strategies, level of evidence, etc. for feasibility and success. /liliWith the TAs, develop the global integrated product access strategy to deliver product differentiation most relevant to payers (e.g., well‑defined target population, clinical endpoints, comparators, outcome measures, utility instruments, Health Economics data), patients, and HCS stakeholders worldwide. /liliWith CLS DAs Pricing team, (co‑)create the international pricing strategy and guidance. With CLS DAs, generate payer negotiation strategy, upskill and prepare countries for their payer negotiations. /liliWith CLS DAs, create innovative patient access and contracting approaches, Managed Entry Agreements (MEAs) and Patient Support Programs (PSPs) as required, to improve patient outcomes and support healthcare system affordability. /liliEnsure that at launch, Novartis brands are supported by a robust payer value proposition particularly featuring core elements; ‘Value for money’ story, strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis. /liliEnsure access team develops and represents expert value evidence input into TPPs, clinical programs (including IEPs), BDLs, and develop any additional non‑registration evidence to meet the needs of medical experts and institutions involved in reimbursement access decisions for key geographies. /liliCollaborate with the HEOR PCO team to ensure full integration of adequate HEOR/evidence deliverables in high quality cross‑franchise strategy. /liliEnsure appropriate focus on priority markets needs into overall strategy. /liliDetermine payer evidence requirements, risks/opportunities in the access landscape and create compelling access strategy with the TA and provide the “access toolbox” to share with priority markets, major HTA archetypes and Budget Impact archetypes. /liliEnsure appropriate and timely access input into BDLs, asset maximization incl. indication sequencing. /liliMaximize value of Novartis assets by creating and executing, together with TAs pricing team, winning pricing strategies. /liliResponsible for building and continually enhancing best‑in‑class Access capabilities to establish and retain competitive advantage in a dynamic market environment. /liliProvide best‑in‑class talent attraction, retention, development and coaching to own team and across access and peer community. /liliReporting of technical complaints / adverse events / special case scenarios related to Novartis products within 24 hours of receipt. /liliDistribution of marketing samples (where applicable). /li /ulh3Essential Requirements /h3ulliEducation: MBA, Ph.D., M.D. or RPh. /lili7+ years of experience in market access roles from pharma. /lili5+ years global or ex‑US regional experience. /liliExperience working early in drug development lifecycle. /liliProduct launch experience. /liliCross functional and matrix influential experience across a team of multiple stakeholders. /liliExperience in driving commercial strategy driven through access or HEOR or pricing expertise. /liliProficient English, both written and spoken. /li /ulh3Desirable Requirements /h3ulli10+ years of experience in market access role from Pharma. /liliHematology therapeutic area experience. /li /ulh3Benefits /h3pRead our handbook to learn about all the ways we’ll help you thrive personally and professionally: Novartis Life Handbook. /ph3Accessibility Statement /h3pNovartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an email to and let us know the nature of your request and your contact information. Please include the job requisition number in your message. /ph3Diversity Inclusion /h3pNovartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve. /p /p #J-18808-Ljbffr